We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Risk of Cardiovascular Disease Linked to Apolipoprotein E Variants

By LabMedica International staff writers
Posted on 29 Sep 2014
Print article
Image: Illustration of the apoER2 receptor protein shows the structure of the entire protein in detail (Photo courtesy of Wikimedia Commons).
Image: Illustration of the apoER2 receptor protein shows the structure of the entire protein in detail (Photo courtesy of Wikimedia Commons).
The apoE4 variant form of circulating apolipoprotein E (apoE) leads to increased risk of cardiovascular disease by blocking binding of the normal apoE3 form to the apoliprotein E receptor 2 (apoER2) in the membranes of endothelial cells lining the walls of blood vessels and by interacting with the receptor without stimulating production of anti-inflammatory nitric oxide (NO).

Nitric oxide is a crucial physiological messenger molecule that plays a role in blood pressure regulation, control of blood clotting, immune defense, digestion, the senses of sight and smell, and possibly learning and memory. In addition to heightened susceptibility to cancer and neurodegenerative diseases, nitric oxide deficiency has been linked to diverse disease processes such as diabetes, stroke, hypertension, impotence, septic shock, and long-term depression.

ApoER2 is a membrane protein made up of 870 amino acids. It is separated into a ligand binding domain of eight ligand binding regions, an EGF-like domain containing three cysteine-rich repeats, an O-linked glycosylation domain of 89 amino acids, a transmembrane domain of 24 amino acids, and a cytoplasmic domain of 115 amino acids, including an arginine-proline-any amino acid-tyrosine (NPXY) motif.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) worked with cell culture and mouse models to determine how the interaction between apoE variants and the apoER2 receptor influence risk of developing cardiovascular disease.

They reported in the September 2, 2014, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that in endothelial cells apoE3 binding to ApoER2 stimulated endothelial NO synthase (eNOS) and endothelial cell migration, and it also attenuated monocytes-endothelial cell adhesion. However, apoE4 did not stimulate eNOS or endothelial cell migration or dampen cell adhesion, and alternatively it selectively inhibited apoE3/apoER2 actions. Approximately 15% of individuals possess the gene coding for apoE4, and these individuals are at increased risk of developing atherosclerosis and coronary heart disease.

The investigators also identified in endothelium a nonfunctional variant of apoER2, apoER2-R952Q, which failed to generate production of NO after interaction with apoE3.

"We believe that we have identified one mechanism by which apoE3 promotes a healthy cardiovascular system and why a genetic variant, apoE4, is detrimental," said senior author Dr. Philip Shaul, professor of pediatrics at the University of Texas Southwestern Medical Center. "An important mechanism that is lost when people possess apoE4 is the ability to produce NO, which leads to a loss of both the reparative and anti-inflammatory capacities of the endothelium. Now, knowing this information, we believe such individuals may benefit from treatment with an NO donor. There is a form of aspirin, for instance, that is an NO donor."

Related Links:

University of Texas Southwestern Medical Center


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Unit-Dose Packaging solution
HLX
New
Serum Toxicology Benzodiazepine Assay
DRI Serum Toxicology Benzodiazepine Assay
New
Urine Drug Test
Instant-view Methadone Urine Drug Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Schematic overview of maternal biomarker discovery using cell-free RNA during pregnancy (Photo courtesy of Circulation Research (2024). DOI: 10.1161/CIRCRESAHA.124.325024)

Maternal Blood Test Identifies Congenital Heart Diseases in Fetus

Each year, around 1,000 children are born with a single ventricle heart defect (SVHD), a condition where one of the heart's lower chambers is underdeveloped, too small, or missing a valve.... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.